13 completed. 10 Phase 4, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 10 |
| Phase 3 | 3 | Completed 3 |
Follow Glargine insulin: new trials by email Literature Review of Glargine insulin trials Research Report on Glargine insulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing the Safety and Efficacy of Insulin GLARGINE and DEGLUDEC in Glucocorticoid Induced HYPERGLYCEMIA in Hospitalized Patients". Degludec insulin, Glargine insulin - Glucocorticoid Induced Hyperglycemia | Phase 4 | Completed | Max Healthcare Insititute Limited | 79 | 2023-09-01 | 2026-05-20 |
| Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables Dulaglutide, Aspart insulin, Glargine - Diabetes Mellitus | Phase 4 | Completed | University of Palermo | 92 | 2017-04-01 | 2019-01-31 |
| A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin Saxagliptin, Onglyza, Dapagliflozin, Farxiga, Glargine insulin - Type 2 Diabetes Mellitus | Phase 3 | Completed | AstraZeneca | 650 | 2015-10-20 | 2018-12-11 |
| Glargine Versus NPH in Patients With Chronic Kidney Disease Glargine insulin, NPH insulin - Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 4 | Completed | University of Sao Paulo General Hospital | 34 | 2013-12-01 | 2017-12-20 |
| Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) Glargine Insulin, Regular insulin - Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition | Phase 4 | Completed | King Faisal Specialist Hospital & Research Center | 61 | 2013-03-01 | 2016-02-25 |
| Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients Metformin, Glargine insulin, Glulisine - Poor Glycemic Control | Phase 3 | Completed | Emory University | 175 | 2012-10-01 | 2018-09-24 |
| The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients Glargine insulin, Lispro insulin, NPH Insulin - Hyperglycemia, Diabetes Mellitus | Phase 4 | Completed | Baylor College of Medicine | 37 | 2010-09-01 | 2017-02-08 |
| Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital Glargine insulin - Diabetes | Phase 4 | Completed | University of Colorado, Denver | 43 | 2010-09-01 | 2021-08-06 |
| Study of Glycemic Control on Liver Transplantation Outcomes Insulin - Evidence of Liver Transplantation, Hyperglycemia | Phase 4 | Completed | Northwestern University | 164 | 2009-04-01 | 2016-12-23 |
| Insulin Therapy in the Hospital Comparing Two Protocols Glargine insulin, NPH insulin and regular insulin, lispro insulin - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Cook County Health | 60 | 2006-12-01 | 2009-09-09 |
| The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes Exenatide, Glargine Insulin - Type 2 Diabetes Mellitus | Phase 4 | Completed | Joslin Diabetes Center | 72 | 2006-08-01 | 2018-01-09 |
| Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes glargine insulin - Type 1 Diabetes | Phase 4 | Completed | Baylor College of Medicine | 36 | 2006-06-01 | 2016-07-14 |
| Insulin Glargine Vs Standard Insulin Therapy Glargine insulin - Cystic Fibrosis Related Diabetes | Phase 3 | Completed | University of Minnesota | 20 | 2003-04-01 | 2005-09-22 |
Diabetes Mellitus (5) · Diabetes Mellitus, Type 2 (4) · Hyperglycemia (3) · Insulin Resistance (3) · Cystic Fibrosis (1) · Diabetes Mellitus, Type 1 (1) · Hyperphagia (1) · Hypoglycemia (1) · Rejection, Psychology (1) · Renal Insufficiency, Chronic (1)
Baylor College of Medicine (2) · AstraZeneca (1) · Cook County Health (1) · Emory University (1) · Joslin Diabetes Center (1) · King Faisal Specialist Hospital & Research Center (1) · Max Healthcare Insititute Limited (1) · Northwestern University (1) · University of Colorado, Denver (1) · University of Minnesota (1) · University of Palermo (1) · University of Sao Paulo General Hospital (1)
United States (9) · Brazil (1) · Czechia (1) · Denmark (1) · Hungary (1) · India (1) · Italy (1) · Mexico (1) · Poland (1) · Romania (1) · Saudi Arabia (1) · South Africa (1) · Spain (1) · Sweden (1)
Antoinette Moran, MD (1) · Boris Draznin, M.D. (1) · Edward S. Horton, MD (1) · Evelyn Lacuesta, MD (1) · Glenn R Cunningham, MD (1) · Guillermo E Umpierrez, MD (1) · Hakeam A Hakeam, MS., BCPS (1) · Leon Fogelfeld, MD (1) · Marcia S Queiroz, MD, PhD (1) · Mark E Molitch, M.D. (1) · Rubina A Heptulla, MD (1) · Yannis Guerra, MD (1)
PMID 18847622, PMID 21454236, PMID 31167892, PMID 31383366, PMID 33166419, PMID 37526194, PMID 39963952
2015 (1)